Skip to main content

Table 1 Correlations of CD133 expression with clinicopathological parameters in the Stage IIIB colon carcinomas

From: Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Variables

 

gender

age

Invasive depth

Sites of primary mass

Grades

Pathological classifications

The percentage of CD133+ cells

gender

P

.

.242

.541

.792

.129

.129

.785

age

P

.242

.

.312

.075

.455

.869

.249

Invasive depth

P

.541

.312

.

.895

.272

.426

.499

Sites of primary mass

P

.792

.075

.895

.

.936

.022*

.786

Grades

P

.129

.455

.272

.936

.

.000**

.536

Pathological classifications

P

.129

.869

.426

.022*

.000**

.

.333

The percentage of CD133+ cells

P

.785

.249

.499

.786

.536

.333

.

  1. *: P < 0.05; **: P < 0.001